Skip to main content
OpenTrials

Clinical trial condition

Immune Thrombocytopenic Purpura

Explore clinical trials studying Immune Thrombocytopenic Purpura. Study availability and eligibility vary by location and protocol.

36 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Immune Thrombocytopenic Purpura trial results

Completed

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

NCT00621894

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of California San Diego Medical Center San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Davis, Posteraro and Wasser, MD's LLP Manchester, Connecticut, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Completed

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

NCT02077192

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Bleeding & Clotting Disorders Institute Peoria, Illinois, United States
  • Horizon Oncology Research, Inc Lafayette, Indiana, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View all 55 locations
View Trial Details
Completed

A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

NCT01621204

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • Hamilton Health Sciences Hamilton, Ontario, Canada
  • London Health Sciences Center London, Ontario, Canada
View Trial Details
Completed

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

NCT02273960

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Univ. Of Southern Calif. /Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • Columbus Regional Research Institute Columbus, Georgia, United States
View all 20 locations
View Trial Details
Completed

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

NCT02076399

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Lakeland Regional Cancer Center Lakeland, Florida, United States
  • Bleeding & Clotting Disorders Institute Peoria, Illinois, United States
View all 52 locations
View Trial Details
Completed

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

NCT00718692

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Univ Nebraska Med Ctr. UNMC, 1005 Omaha, Nebraska, United States
  • Hospital of the University of Pennsylvania, Site 1002 Philadelphia, Pennsylvania, United States
  • 2085 Henry Tecklenburg Drive, 1001 Charleston, South Carolina, United States
  • Research Site 3203 Bruges, Belgium
View all 59 locations
View Trial Details

Related conditions